- The current view of the diagnosis and new treatment options of Cystic Fibrosis2016 | Faculty of Medicine in Pilsen
- Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR2015 | Second Faculty of Medicine
- Human epididymis protein 4 (HE4) plasma concentration inversely correlates with the improvement of cystic fibrosis lung disease in p.Phe508del-CFTR homozygous cases treated with the CFTR modulator lumacaftor/ivacaftor combination2023 | Second Faculty of Medicine
- CFTR protein modulators2019 | Second Faculty of Medicine
- Enhanced Expression of Human Epididymis Protein 4 (HE4) Reflecting Pro-Inflammatory Status Is Regulated by CFTR in Cystic Fibrosis Bronchial Epithelial Cells2021 | Second Faculty of Medicine
- Current possibilities of causal therapy of cystic fibrosis in childhood2021 | Faculty of Medicine in Pilsen
- Case report of two adults with F508del/3849+10 kb C > T genotype regaining exocrine pancreatic function following treatment with elexacaftor/tezacaftor/ivacaftorPublication without faculty affiliation
- Elexacaftor-tezacaftor-ivacaftor in patients with cystic fibrosis ineligible for clinical trials: a 24-week observational study2023 | Second Faculty of Medicine